@ARTICLE{
author={Fleischmann Roy M|,Spencer-Green George T|,Fan Frank|,Frankovic Biliana|,Luo Xia|,Hoock Thomas|,Damjanov Nemanja S|},
year={2011},
title={Dose Ranging Study of VX-509, An Oral Selective JAK3 Inhibitor, As Monotherapy in Patients with Active Rheumatoid Arthritis (RA).},
journal={ARTHRITIS AND RHEUMATISM},
volume={63},
number={12},
pages={4042-4042},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Damjanov Nemanja S|,Kauffman Robert S|,Spencer-Green George T|},
year={2009},
title={Efficacy, Pharmacodynamics, and Safety of VX-702, a Novel p38 MAPK Inhibitor, in Rheumatoid Arthritis Results of Two Randomized, Double-Blind, Placebo-Controlled Clinical Studies},
journal={ARTHRITIS AND RHEUMATISM},
volume={60},
number={5},
pages={1232-1241},
document_type={Article},
}